ClinicalTrials.gov
public full text
Public Domain
Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients
In this multi-center international study, our aim is to determine the effectiveness of HCQ for primary thrombosis prophylaxis in persistently aPL-positive but thrombosis-free patients without systemic autoimmune diseases.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP#1243095
- Hydroxychloroquine (HCQ) in Pediatric Interstitial Lung Disease (ILD)#1231255
- Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT#886740
- Hydroxychloroquine Administration for Reduction of Pexophagy#825584
- Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients#1172769
Record · ID 1430949
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive